Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...
Widespread and longstanding abuse of the 340B federal drug program has prompted state lawmakers to take action.
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...
Unicameral committees start taking testimony at 1:30 p.m. on bills scheduled that day. Livestreams of hearings and texts of ...
Governor Mike Braun signed multiple executive orders, ranging from affordable health insurance to abortion, with a focus on ...
HRSA said that drug rebates are illegal under the 340B program and warned the drugmaker it could face significant fines or lose its eligibility for Medicaid or Medicare Part B participation if it ...
A dark money group is attacking a Utah GOP senator's bill meant to protect access to a federal program requiring drug ...
On January 20, a new administration began addressing our nation’s pressing problems, including health care costs. Drug costs ...
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other financial assistance programs implicated by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback